Cargando…

Screening Potential Drugs for the Development of NAFLD Based on Drug Perturbation Gene Set

Nonalcoholic fatty liver disease (NAFLD) has become one of the problems affecting the health of the population worldwide. The progressive disease includes nonalcoholic steatohepatitis (NASH) and fibrosis, which with no approved therapy, system identification of effective drugs remains challenging. I...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gao, Zhengzheng, Dai, Lina, Zhang, Haifeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9034918/ https://www.ncbi.nlm.nih.gov/pubmed/35469222 http://dx.doi.org/10.1155/2022/7606716

Ejemplares similares

Drug perturbation gene set enrichment analysis (dpGSEA): a new transcriptomic drug screening approach
por: Fang, Mike, et al.
Publicado: (2021)

Potential Drug Prediction of Glioblastoma Based on Drug Perturbation-Induced Gene Expression Signatures
por: Zhu, Bochi, et al.
Publicado: (2021)

Perturbation of the circadian clock and pathogenesis of NAFLD
por: Mukherji, Atish, et al.
Publicado: (2020)

Drug-based perturbation screen uncovers synergistic drug combinations in Burkitt lymphoma
por: Tomska, K., et al.
Publicado: (2018)

Therapeutic potential of traditional Chinese medicine for the treatment of NAFLD: A promising drug Potentilla discolor Bunge
por: Ji, Longshan, et al.
Publicado: (2022)

Drug-perturbation-based stratification of blood cancer
por: Dietrich, Sascha, et al.
Publicado: (2017)

Perturbational Gene-Expression Signatures for Combinatorial Drug Discovery
por: Huang, Chen-Tsung, et al.
Publicado: (2019)

Predicting chemosensitivity using drug perturbed gene dynamics
por: Mannheimer, Joshua D., et al.
Publicado: (2021)

Emerging Therapeutic Targets and Experimental Drugs for the Treatment of NAFLD
por: Dibba, Pratima, et al.
Publicado: (2018)

Antidiabetic Drugs in NAFLD: The Accomplishment of Two Goals at Once?
por: Tacelli, Matteo, et al.
Publicado: (2018)

NAFLD and Diabetes: Two Sides of the Same Coin? Rationale for Gene-Based Personalized NAFLD Treatment
por: Xia, Ming-Feng, et al.
Publicado: (2019)

Drug target prioritization by perturbed gene expression and network information
por: Isik, Zerrin, et al.
Publicado: (2015)

Applications of Quantitative Systems Pharmacology (QSP) in Drug Development for NAFLD and NASH and Its Regulatory Application
por: Siler, Scott Q.
Publicado: (2022)

Drug approval prediction based on the discrepancy in gene perturbation effects between cells and humans
por: Park, Minhyuk, et al.
Publicado: (2023)

Discovery of therapeutic agents targeting PKLR for NAFLD using drug repositioning
por: Zhang, Cheng, et al.
Publicado: (2022)

CYP450 drug inducibility in NAFLD via an in vitro hepatic model: Understanding drug-drug interactions in the fatty liver
por: Rey-Bedon, Camilo, et al.
Publicado: (2022)

Inference of dynamic biological networks based on responses to drug perturbations
por: Berlow, Noah, et al.
Publicado: (2014)

Screening for NAFLD—Current Knowledge and Challenges
por: Forlano, Roberta, et al.
Publicado: (2023)

Gold Nanoparticles Perturb Drug-Metabolizing Enzymes and Antioxidants in the Livers of Male Rats: Potential Impact on Drug Interactions
por: Al-Hamadani, Mohammed Y I, et al.
Publicado: (2020)

Recent Developments in NAFLD
por: Mantovani, Alessandro, et al.
Publicado: (2022)

Redefinition of Fatty Liver Disease from NAFLD to MAFLD through the Lens of Drug Development and Regulatory Science
por: Fouad, Yasser, et al.
Publicado: (2022)

Identifying anti-cancer drug response related genes using an integrative analysis of transcriptomic and genomic variations with cell line-based drug perturbations
por: Sun, Yi, et al.
Publicado: (2016)

Early-life stress perturbs the epigenetics of Cd36 concurrent with adult onset of NAFLD in mice
por: Fu, Qi, et al.
Publicado: (2023)

Identifying key genes and drug screening for preeclampsia based on gene expression profiles
por: Xu, Zhengfang, et al.
Publicado: (2020)

The potential role of the three-dimensional-bioprinting model in screening and developing drugs
por: Deng, Chao-Lin, et al.
Publicado: (2022)

Microfluidic Applications in Drug Development: Fabrication of Drug Carriers and Drug Toxicity Screening
por: Zhao, Pei, et al.
Publicado: (2022)

Potential screening indicators for early diagnosis of NAFLD/MAFLD and liver fibrosis: Triglyceride glucose index–related parameters
por: Xue, Yan, et al.
Publicado: (2022)

Mendelian randomization for studying the effects of perturbing drug targets
por: Gill, Dipender, et al.
Publicado: (2021)

Perturbations of cancer cell metabolism by the antidiabetic drug canagliflozin
por: Papadopoli, David, et al.
Publicado: (2021)

Dr.VAE: improving drug response prediction via modeling of drug perturbation effects
por: Rampášek, Ladislav, et al.
Publicado: (2019)

Lessons on Drug Development: A Literature Review of Challenges Faced in Nonalcoholic Fatty Liver Disease (NAFLD) Clinical Trials
por: Chen, Joel Yeh Siang, et al.
Publicado: (2022)

PPARα in the Epigenetic Driver Seat of NAFLD: New Therapeutic Opportunities for Epigenetic Drugs?
por: Theys, Claudia, et al.
Publicado: (2022)

Learning epistatic gene interactions from perturbation screens
por: Elmes, Kieran, et al.
Publicado: (2021)

Zinc and Iron Homeostasis: Target-Based Drug Screening as New Route for Antifungal Drug Development
por: Simm, Claudia, et al.
Publicado: (2019)

An Algorithmic Approach to NAFLD Screening: From PCP to Specialist
por: Trivedi, Hirsh D.
Publicado: (2020)

Efficient computation of minimal perturbation sets in gene regulatory networks
por: Garg, Abhishek, et al.
Publicado: (2013)

The COVID-19 Gene and Drug Set Library
por: Kuleshov, Maxim V., et al.
Publicado: (2020)

The COVID-19 Drug and Gene Set Library
por: Kuleshov, Maxim V., et al.
Publicado: (2020)

An Update on the Chemokine System in the Development of NAFLD
por: Nagata, Naoto, et al.
Publicado: (2022)

Relationship of FTO gene variations with NAFLD risk in Chinese men
por: Chen, Xuefen, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_bpq5prg1lrbq01h8ke0u3q07d6